Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Relationship between CD36 expression and clinicopathology in cervical cancer

From: CD36 promotes the epithelial–mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β

Group CD36 expression
n Positive Negative χ2 P
Age
 ≥ 50 66 51 (77.3%) 15 (22.7%) 0.870 0.351
 < 50 67 47 (70.1%) 20 (29.9%)
Differentiation
 Good 48 25 (52.1%) 23 (47.9%) 18.351 0.000*
 Moderate 42 35 (83.3%) 7 (16.7%)
 Poor 43 38 (88.4%) 5 (11.6%)
Clinical stage
 I 87 66 (75.9%) 21 (24.1%) 0.615 0.433
 II–IV 46 32 (69.6%) 14 (30.4%)
Lymph node metastasis
 Positive 79 64 (81.0%) 15 (19.0%) 5.389 0.020*
 Negative 54 34 (63.0%) 20 (37.0%)
  1. * P < 0.05